Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
BPC-157 has been shown to counteract corticosteroid-induced damage to tendons
In controlled research settings, AOD-9604 is commonly investigated in relation to: Metabolic pathway signaling Peptide-mediated biological processes Cellular regulation mechanisms Biochemical pathway interactions Researchers exploring similar pathways often also investigate Tirzepatide peptide and Cagrilintide peptide , which are studied in related metabolic and endocrine research models
Common (Oral): Gastrointestinal disturbance, diarrhea, nausea, vomiting, fatigue, conjunctival irritation, skin rash (26) (28) Other: Hypotension, anaphylaxis, asthma attacks, headache (29) Case reports Photosensitivity not attributable to location, season, or concomitant medication: Occurred among pulmonary fibrosis patients more frequently with acetylcysteine than placebo in combination with pirfenidone (39)
Some countries prohibit importing peptides without prescriptions
